Table 1 Correlation of CXCL12 expression with clinical parameters
From: CXCL12 expression by healthy and malignant ovarian epithelial cells
Patient number | Pvaluea | ||
|---|---|---|---|
CXCL12low/moderate | CXCL12high | ||
Scores (0-4) | Scores (5-7) | ||
Histotype | |||
Serous (n = 125) | 66 | 59 | 0.90 (NS) |
Non serous (n = 58) | 31 | 27 | |
HER2 | |||
Negative (n = 171) | 93 | 78 | 0.57 (NS) |
Positive (n = 10) | 4 | 6 | |
Undetermined (n = 2) | |||
FIGO stage | |||
I+II (n = 27) | 14 | 13 | 0.91 (NS) |
III+IV (n = 155) | 82 | 73 | |
Undetermined (n = 1) | |||
Ascites | |||
Absence (n = 74) | 37 | 37 | 0.45 (NS) |
Presence (n = 86) | 47 | 39 | |
Undetermined (n = 23) | |||
Residual tumor after initial laparatomy | |||
>1 cm (n = 83) | 40 | 43 | 0.98 (NS) |
≤1 cm (n = 24) | 11 | 13 | |
Undetermined (n = 76) | |||